June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
A Functional Link Between the Melanocortin and Adenosinergic Pathways in the Expression of Protective Regulatory Immunity in the Post-EAU Spleen
Author Affiliations & Notes
  • Darren Lee
    Ophthalmology, Boston University School of Med, Boston, MA
  • Andrew Taylor
    Ophthalmology, Boston University School of Med, Boston, MA
  • Footnotes
    Commercial Relationships Darren Lee, None; Andrew Taylor, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3667. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Darren Lee, Andrew Taylor; A Functional Link Between the Melanocortin and Adenosinergic Pathways in the Expression of Protective Regulatory Immunity in the Post-EAU Spleen. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3667.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: IRBP-specific regulatory immunity is found in the spleen of mice that have recovered from experimental autoimmune uveoretinitis (EAU). This post-EAU regulatory immunity requires post-EAU Treg cells to be activated by regulatory MC5r+Ly-6G+CD11b+ post-EAU APC. Since stimulation of the adenosine 2A receptor (A2Ar) on T cells triggers anti-inflammatory and regulatory activity, and there may be a link between the melanocortin and adenosine pathways we examined the role of A2Ar in the induction of regulatory immunity in the post-EAU spleen.

Methods: Primary spleen APC were treated with α−MSH, stained for CD11b, Ly-6G, ectoenzymes CD39 and CD73, and analyzed by flow cytometry. C57BL/6 (WT) and A2Ar(-/-) mice were immunized with IRBPp 1-20 in CFA to induce EAU. WT EAU mice were treated during EAU with 3 systemic injections of the A2Ar agonist, CGS21680 (CGS). The fundus was monitored until resolution, and reactivated post-EAU T cells were stained for FoxP3. At resolution of EAU, spleen APC and T cells were collected from A2Ar(-/-) or WT mice. WT APC were used to restimulate A2Ar(-/-) T cells or A2Ar(-/-) APC restimulated Treg cells and transferred to recipient EAU mice.

Results: CD39 and CD73 expression was modestly higher on Ly-6G+ APC compared to Ly-6G- APC. α-MSH treated Ly-6G+ APC showed a dramatic upregulation of CD73 not observed on Ly-6G- APC; CD39 expression increased slightly on Ly-6G+ APC, whereas, Ly-6G- showed decreased CD39 expression. CGS treatment accelerated the resolution of EAU and suppressed effector T cells in the spleen. EAU duration and severity was nearly identical in WT and A2Ar(-/-) mice. However, post-EAU A2Ar(-/-) mice lacked regulatory immunity in the spleen and had significantly less CD25+ FoxP3+ T cells. APC from A2Ar(-/-) mice activated post-EAU Treg cells to suppress EAU in recipient mice. In contrast, mice that received post-EAU APC and post-EAU A2Ar(-/-) T cells showed a similar course of disease compared to untreated mice.

Conclusions: T cell expression of A2Ar is required for the regulatory Ly-6G+ CD11b+ APC to activate Treg cells. This report identified a link between the melanocortin and adenosinergic pathways through MC5r stimulation on the Ly-6G+ APC to augment adenosine generation to promote Treg cell induction through A2Ar.

Keywords: 555 immunomodulation/immunoregulation • 553 immune tolerance/privilege • 746 uveitis-clinical/animal model  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.